Hoth Therapeutics (HOTH) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

HOTH Hoth Therapeutics

Watchlist

1.4800
+0.1200+8.82%

Trading Jan 23 15:41 ET

10.22MMarket Cap-1.17P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4
Moomoo NewsJan 23 07:31 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Hoth Therapeutics, Maintains $4 Price Target
BenzingaJan 23 07:06 ET
Express News | Hoth Therapeutics Announces Newly Secured Patents, Says IP Will Be Used To Pursue Further Indications For HT-001 Cancer Therapeutic
BenzingaJan 21 08:30 ET
Hoth Therapeutics Expands Intellectual Property Portfolio With Acquisition of New Patent Applications
Yahoo FinanceJan 21 08:29 ET
Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025
PR NewswireJan 17 08:29 ET
Hoth Therapeutics Shares Recover; Company Has No Plans for Offering
WSJJan 8 14:44 ET

Comments

NurseTrader Mmoo

Jan 21 09:29

$Hoth Therapeutics (HOTH.US)$ sleep well ❤️‍🩹

Jaguar8

Jan 21 07:29

NEWS

$Hoth Therapeutics (HOTH.US)$
Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications
Tuesday, 21st January at 8:29 am
IP will be used to pursue further indications for HT-001 Cancer Therapeutic
NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio through the acquisition and expansion of patent applications ...